Bioness Inc is a medical device company headquartered in Valencia, California, USA, specializing in functional electrical stimulation (FES) systems for the rehabilitation and assistance of people with neurological conditions affecting movement. Founded in 2003, Bioness developed the first FDA-cleared wireless functional electrical stimulation system for drop foot and has expanded to address a broad range of motor impairments including hand and finger dysfunction, gait instability, and upper extremity paresis[1].
The company's core technology platform uses surface electrical stimulation to activate muscles in precise patterns synchronized with intended movement. This approach enables people with motor impairments to perform functional tasks — walking, grasping objects, maintaining balance — that would otherwise be difficult or impossible. Bioness devices are used by people recovering from stroke, living with Parkinson's disease, managing multiple sclerosis, recovering from spinal cord injury, and other neurological conditions.
Bioness operates as a subsidiary of Bioventus LLC, following Bioventus's acquisition of the company's orthobiologics and rehabilitation businesses in 2021.
Bioness was founded with the goal of making functional electrical stimulation practical and accessible for daily use. The company's approach was to miniaturize and wirelessly connect FES technology so that it could be worn continuously throughout daily life, rather than limited to clinical therapy sessions. This vision was enabled by advances in microelectronics, battery technology, and wireless communication that made wearable stimulation systems feasible.
The company's foundational technology was the NESS L300 system (Neural Electrical Stimulation System), which received FDA 510(k) clearance in 2007 as the first wireless FES system for foot drop. The wireless design was a significant advancement over earlier tethered systems, allowing users to move freely without connected wires.
During this period, Bioness expanded its product line significantly:
Functional electrical stimulation uses small electrical currents applied through surface electrodes to activate peripheral nerves, causing the connected muscles to contract. When applied in precise patterns synchronized with the user's intended movement, FES can:
Historical Foundation: The use of electrical stimulation for gait assistance dates to Liberson et al. (1961), who first described "functional electrotherapy" for drop foot correction[2]. Since then, FES technology has evolved from bulky laboratory systems to compact, wireless, user-friendly devices suitable for daily use[3].
Drop foot results from weakness or dysfunction of the ankle dorsiflexors — primarily the tibialis anterior muscle — preventing the foot from clearing the ground during swing phase of gait. The condition commonly results from upper motor neuron lesions including stroke, traumatic brain injury, MS, and PD.
FES Treatment of Drop Foot: During the swing phase of walking, FES activates the tibialis anterior to dorsiflex the ankle, allowing the toes to clear the ground. As the heel strikes, stimulation ceases, allowing the foot to make contact with the floor. Over repeated daily use, this patterned stimulation may also contribute to motor relearning and reduce spasticity[4].
The L300 Go is Bioness's flagship wireless foot drop system, representing the company's most advanced FES technology[5]:
Components:
| Component | Description |
|---|---|
| Go Unit | Leg-worn stimulation unit (attachable to calf or thigh) |
| Smart Electrode Array | Multi-contact electrode for optimal muscle targeting |
| Insole Sensor | Heel pressure sensor for phase detection |
| Tilt Sensor | Accelerometer for walking phase detection |
| Charging Case | Portable charging system |
Key Features:
Clinical Utility: The L300 Go enables consistent, all-day correction of foot drop during daily activities — not just during formal therapy sessions. This continuous use model is designed to maximize both functional benefit and neuroplastic opportunity[6].
The L300 Plus extends foot drop correction to patients with bilateral (both legs) involvement[7]:
Applications: Bilateral foot drop commonly occurs in MS, spinal cord injury, and advanced PD. The L300 Plus addresses a critical gap in the FES market — prior to its introduction, patients with bilateral foot drop had limited options.
The H200 provides FES-assisted hand function for patients with upper extremity paresis[8]:
Functionality:
Clinical Applications:
The H200 uses a cuff-based design worn on the forearm, with surface electrodes positioned over the radial nerve and finger extensor muscles. The system can be used during therapy sessions or incorporated into daily activities.
The research-grade NESS L300 system provides advanced capabilities for clinical research[9]:
FES for foot drop in PD has been studied since the late 2000s, with growing evidence supporting its use:
Wilkinson et al. (2014)[10]:
Smith et al. (2017)[11]:
Liberson et al. (1961) — Historical Foundation[2:1]:
Kottink et al. (2008)[4:1]:
Everett et al. (2013)[6:1]:
Hardingham et al. (2008)[12]:
Sabut et al. (2011)[13]:
Immediate Effect (Compensation): FES provides real-time functional compensation — when activated, the muscles contract and produce the desired movement. This is a compensatory mechanism that does not depend on neural repair.
Training Effect (Recovery): Over time and with consistent use, FES may contribute to genuine motor recovery through:
The relative contribution of compensatory vs. restorative mechanisms varies by patient, condition, and treatment parameters.
Foot drop is a common gait disturbance in Parkinson's disease, arising from bradykinesia (slowness of movement), rigidity, and in some cases medication-related fluctuations. The L300 Go provides:
Gait Cycle Correction:
Practical Benefits:
Some PD patients experience freezing of gait — a sudden, episodic inability to continue walking. FES may help by:
For PD patients with general slowness and stiffness, the H200 hand system can:
FES is particularly suitable for PD because:
Bioness systems use a fully wireless architecture:
The systems use sophisticated algorithms to optimize stimulation:
| Region | Status | Products |
|---|---|---|
| FDA (USA) | 510(k) cleared | L300 Go, L300 Plus, H200 |
| CE Mark (EU) | Class IIa medical device | Full product line |
| Health Canada | Licensed | L300, H200 |
| TGA (Australia) | Approved | L300, H200 |
| PMDA (Japan) | Cleared | L300 |
Bioness competes in the FES and rehabilitation technology markets:
| Company | Key Products | Focus |
|---|---|---|
| Bioness | L300 Go, H200 | Wireless FES, daily use |
| O得名 (ODM) | FES devices | General electrical stimulation |
| Compex (DJO) | Sport FES | Consumer and sports recovery |
| Hocoma | VALEO | FES integrated with robotics |
| Restorative Therapies | RT300 | FES cycling systems |
| Odstock Medical | OML | Drop foot stimulation, UK |
Bioness Differentiation:
Liberson W, et al. Functional electrotherapy in gait rehabilitation. Arch Phys Med Rehabil. 1961. ↩︎ ↩︎
Singer M, et al. Electrical stimulation for neurological rehabilitation. Curr Opin Neurol. 2006. ↩︎
Kottink A, et al. FES for foot drop in post-stroke patients. J Rehabil Med. 2008. ↩︎ ↩︎
Everett P, et al. Functional electrical stimulation for foot drop. J Rehabil Res Dev. 2013. ↩︎ ↩︎
Wilkinson J, et al. FES for foot drop in Parkinson's disease. IEEE Trans Neural Syst Rehabil Eng. 2014. ↩︎
Smith C, et al. FES for gait in Parkinson's disease - systematic review. Parkinsonism Relat Disord. 2017. ↩︎
Hardingham Y, et al. Bioness L300 clinical outcomes in gait. J Assist Technol. 2008. ↩︎
Sabut S, et al. FES gait restoration in hemiparetic stroke. Artif Organs. 2011. ↩︎
Taub E, et al. CI therapy for stroke and PD. Neurorehabil Neural Repair. 2012. ↩︎